IBDEI1EL ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23421,1,4,0)
 ;;=4^K82.9
 ;;^UTILITY(U,$J,358.3,23421,2)
 ;;=^5008875
 ;;^UTILITY(U,$J,358.3,23422,0)
 ;;=H40.9^^113^1129^7
 ;;^UTILITY(U,$J,358.3,23422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23422,1,3,0)
 ;;=3^Glaucoma, unspec
 ;;^UTILITY(U,$J,358.3,23422,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,23422,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,23423,0)
 ;;=M10.9^^113^1129^8
 ;;^UTILITY(U,$J,358.3,23423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23423,1,3,0)
 ;;=3^Gout, unspec
 ;;^UTILITY(U,$J,358.3,23423,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,23423,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,23424,0)
 ;;=K21.9^^113^1129^1
 ;;^UTILITY(U,$J,358.3,23424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23424,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,23424,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,23424,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,23425,0)
 ;;=R31.0^^113^1129^9
 ;;^UTILITY(U,$J,358.3,23425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23425,1,3,0)
 ;;=3^Gross Hematuria
 ;;^UTILITY(U,$J,358.3,23425,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,23425,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,23426,0)
 ;;=B02.9^^113^1130^21
 ;;^UTILITY(U,$J,358.3,23426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23426,1,3,0)
 ;;=3^Herpes (Zoster) w/o complications
 ;;^UTILITY(U,$J,358.3,23426,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,23426,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,23427,0)
 ;;=B19.10^^113^1130^17
 ;;^UTILITY(U,$J,358.3,23427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23427,1,3,0)
 ;;=3^Hepatitis B,Viral Unspec
 ;;^UTILITY(U,$J,358.3,23427,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,23427,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,23428,0)
 ;;=B17.10^^113^1130^2
 ;;^UTILITY(U,$J,358.3,23428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23428,1,3,0)
 ;;=3^Acute Hepatitis C w/o hepatic coma
 ;;^UTILITY(U,$J,358.3,23428,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,23428,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,23429,0)
 ;;=B18.2^^113^1130^20
 ;;^UTILITY(U,$J,358.3,23429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23429,1,3,0)
 ;;=3^Hepatitis C,Viral,Chronic
 ;;^UTILITY(U,$J,358.3,23429,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,23429,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,23430,0)
 ;;=E05.90^^113^1130^27
 ;;^UTILITY(U,$J,358.3,23430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23430,1,3,0)
 ;;=3^Hyperthyroidism w/o Thyrotoxic Crisis/Storm,Unspec
 ;;^UTILITY(U,$J,358.3,23430,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,23430,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,23431,0)
 ;;=E03.9^^113^1130^33
 ;;^UTILITY(U,$J,358.3,23431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23431,1,3,0)
 ;;=3^Hypothyroidism, unspec
 ;;^UTILITY(U,$J,358.3,23431,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,23431,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,23432,0)
 ;;=E16.2^^113^1130^30
 ;;^UTILITY(U,$J,358.3,23432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23432,1,3,0)
 ;;=3^Hypoglycemia, unspec
 ;;^UTILITY(U,$J,358.3,23432,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,23432,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,23433,0)
 ;;=E78.0^^113^1130^23
 ;;^UTILITY(U,$J,358.3,23433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23433,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,23433,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,23433,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,23434,0)
 ;;=E78.0^^113^1130^28
 ;;^UTILITY(U,$J,358.3,23434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23434,1,3,0)
 ;;=3^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,23434,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,23434,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,23435,0)
 ;;=E78.5^^113^1130^25
